4T1-hHER2-Luc
Strain Information
表現型データ
Fig1. HER2 expression in 4T1-hHER2 cell lines.
Fig2. In vivo validation of 4T1-hHER2 in BALB/c mice.
BALB/c mice were inoculated with 4T1-hHER2 subcutaneously at 1×106 cells/mouse inoculum for tumor development.
Fig3. HER2 expression in tumors after in vivo growth of 4T1-hHER2 in wild type BALB/c mice.
The tumors were collected at day 34 post tumor cell inoculation.
関連の系統
あなたも好きかも
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
詳細At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
詳細